Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?

被引：18

作者：

Correll, Christoph U. ^{[1
,2
]}

机构：

[1] N Shore Long Isl Jewish Hlth Syst, Zucker Hillside Hosp, Glen Oaks, NY USA

[2] Albert Einstein Coll Med, Bronx, NY 10467 USA

来源：

JOURNAL OF CLINICAL PSYCHIATRY | 2008年 / 69卷 / 04期

关键词：

D O I：

10.4088/JCP.v69n0422

中图分类号：

B849 [应用心理学];

学科分类号：

040203 [应用心理学];

摘要：

引用

收藏

页码：674 / 675

页数：2

相关论文

共 11 条

[1]

WHEN SYMPTOMS PERSIST - CHOOSING AMONG ALTERNATIVE SOMATIC TREATMENTS FOR SCHIZOPHRENIA [J].

CHRISTISON, GW ;

KIRCH, DG ;

WYATT, RJ .

SCHIZOPHRENIA BULLETIN, 1991, 17 (02) :217-245

[2]

Does antipsychotic polypharmacy increase the risk for metabolic syndrome? [J].

Correll, Christoph U. ;

Frederickson, Anne M. ;

Kane, John M. ;

Manu, Peter .

SCHIZOPHRENIA RESEARCH, 2007, 89 (1-3) :91-100

[3]

CORRELL CU, IN PRESS CNS DRUGS

[4]

Antipsychotic prescribing practices in Connecticut's public mental health system: Rates of changing medications and prescribing styles [J].

Covell, NH ;

Jackson, CT ;

Evans, AC ;

Essock, SM .

SCHIZOPHRENIA BULLETIN, 2002, 28 (01) :17-29

[5]

Polypharmacy in schizophrenia: A fuzzy concept [J].

Freudenreich, O ;

Goff, DC .

JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) :1132-1132

[6]

KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789

[7]

Lehman AF, 2004, AM J PSYCHIAT, V161, P1

[8]

Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system - Individual and facility predictors [J].

Leslie, DL ;

Rosenheck, RA .

MEDICAL CARE, 2001, 39 (09) :923-933

[9]

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia [J].

Lewis, Shon W. ;

Barnes, Thomas R. E. ;

Davies, Linda ;

Murray, Robin M. ;

Dunn, Graham ;

Hayhurst, Karen P. ;

Markwick, Alison ;

Lloyd, Helen ;

Jones, Peter B. .

SCHIZOPHRENIA BULLETIN, 2006, 32 (04) :715-723

[10]

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment [J].

McEvoy, JP ;

Lieberman, JA ;

Stroup, TS ;

Davis, SM ;

Meltzer, HY ;

Rosenheck, RA ;

Swartz, MS ;

Perkins, DO ;

Keefe, RSE ;

Davis, CE ;

Severe, J ;

Hsiao, JK .

AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (04) :600-610